The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Combination therapy with CpG oligodeoxynucleotide and imatinib can reverse the drug resistance when applied alone through promoting BAX activation and overcoming BCR-ABL1-independent PI3K/AKT activation.
 
Ling Bai
No Relationships to Disclose
 
Wei Chen
No Relationships to Disclose
 
Wei Li
No Relationships to Disclose
 
Lei Zhou
No Relationships to Disclose
 
Chao Niu
No Relationships to Disclose
 
Jingtao Chen
No Relationships to Disclose
 
Wei Han
No Relationships to Disclose
 
Jiuwei Cui
No Relationships to Disclose